NEUROTAU, INC.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2017-01-01
- Employees
- 1
- Market Cap
- -
- Website
- https://neurotau.com
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Evaluation of Tolfenamic Acid in Individuals With PSP at 12-Weeks
- First Posted Date
- 2020-02-05
- Last Posted Date
- 2020-02-05
- Lead Sponsor
- NeuroTau, Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT04253132
- Locations
- 🇺🇸
Lou Ruvo Center for Brain Health - Cleveland Clinic Nevada, Las Vegas, Nevada, United States
News
No news found